Tenax Therapeutics (TENX) Goodwill (2015 - 2016)

Tenax Therapeutics (TENX) posted quarterly Goodwill of $11.3 million for Q3 2016, little changed on a QoQ basis from $11.3 million in Q2 2016.

Tenax Therapeutics (TENX) Goodwill (2015 - 2016) Analysis & Trends

Tenax Therapeutics has reported Goodwill for 2 years, with the latest figure at $11.3 million in Q3 2016.

Goodwill for Q3 2016 came in at $11.3 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2016 was $11.3 million (changed N/A YoY), and the FY2015 annual result was $11.3 million, changed N/A from the prior year.
Goodwill steadied at $11.3 million in Q3 2016, from $11.3 million in the prior quarter.
Over five years, Goodwill peaked at $11.3 million in Q4 2015 and troughed at $11.3 million in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Tenax Therapeutics	78.47 Mn	78.47 Mn	-

Download Data